Skip to main content
SpringerLink
Log in

Pharmaka mit Wirkung auf den Respirationstrakt

  • Chapter
Pharmakologie und Toxikologie

Part of the book series: Springer-Lehrbuch ((SLB))

  • 854 Accesses

Zusammenfassung

Die häufigsten obstruktiven Atemwegserkrankungen sind das Asthma bronchiale und die chronische obstrukte Bronchitis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Adam D, Ferlinz R, Frei R, Geisler L, Knothe H, Lode H, Shah P (1992) Antibakterielle Therapie bei infektiösen Bronchialerkrankungen. Med Monatsschr Pharm 15: 100–105

    PubMed  CAS  Google Scholar 

  • Appleton S, Smith B, Veale A, Bara A (2001) Long-acting beta 2-agonists for chronic obstructive pulmonary disease (Cochrane Review). In: The Cochrane Library, Issue 1, 2001, Oxford.

    Google Scholar 

  • Asthma im Kindesalter (1992) Arzneimittelbrief 28:97–99

    Google Scholar 

  • Barnes PG (1995) Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med 152:838–860

    Article  PubMed  CAS  Google Scholar 

  • Barnes PJ (1994) Cytokines as mediators of chronic asthma. Am J Respir Crit Care Med 150:542–549

    Google Scholar 

  • Barnes PJ, Adcock I (1992) Anti-inflammatory actions of steroids: Molecular mechanisms. Trends Pharmacol Sci 14:436–441

    Article  Google Scholar 

  • Barnes PJ, Pauwels R (1994) Theophylline in the management of asthma: time for reappraisal. Eur Respir J 7:579–591

    Article  PubMed  CAS  Google Scholar 

  • Barnes PJ (1998) Chronic obstructive pulmonary disease: new opportunities for drug development. Trends Pharmacol Sci 19:415–423

    Article  PubMed  CAS  Google Scholar 

  • Barr RG, Rowe BH, Camargo Jr CA (2001) Methyl-xanthines for exacerbations of chronic obstructive pulmonary disease (Cochrane Review). In: The Cochrane Library, Issue 1, 2001, Oxford.

    Google Scholar 

  • Boulet LP (1994) Long- versus short-acting ß2-agonists. Implications for drug therapy. Drugs 47:207–222

    Article  PubMed  CAS  Google Scholar 

  • Brogden RN, Faulds D (1991) Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airway disease. Drugs 42:895–912

    Article  PubMed  CAS  Google Scholar 

  • Chung KF, Barnes PJ (1988) PAF-antagonists. Their potential role in asthma. Drugs 35:93–103

    Article  PubMed  CAS  Google Scholar 

  • Coleman RA, Johnson M, Nials AT, Vardey CJ (1996) Exosites: their current status, and their relevance to the action of long-acting ß2-adrenoceptor agonists. Trends in Pharmacol Sci 17:324–330

    Article  CAS  Google Scholar 

  • Collis MG, Hourani DMP (1993) Adenosine receptor subtypes. Trends Pharmacol Sci 14:360–366

    Article  PubMed  CAS  Google Scholar 

  • Drazen JM, Israel E, O’Byrne PM (1999) Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 340:197–206

    Article  PubMed  CAS  Google Scholar 

  • Editorial (1999) Behandlung der stabilen chronisch obstruktiven Lungenerkrankung. Arznei-telegramm 9:91–94

    Google Scholar 

  • Giembycz MA (1996) Phosphodiesterase 4 and tolerance to ß2-adrenoceptor agonists. Trends in Pharmacol Sci 17:331–336

    Article  CAS  Google Scholar 

  • Gonzalez JP, Brogden RN (1987) Nedocromil sodium. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airways disease. Drugs 34:560–577

    Article  PubMed  CAS  Google Scholar 

  • Halliday HL (1996) Natural vs Synthetic surfactants in neonatal respiratory distress syndrome. Drugs 51:226–237

    Article  PubMed  CAS  Google Scholar 

  • Hofmann F, Ludwig A, Pfeiffer A, Raeburn D, Giembycz MA (eds) (1994) Cyclic GMP and the control of airways smooth muscle tone. In: Airways smooth muscle biochemical control of contraction and relaxation. Birkhäuser, Basel, pp 253–269

    Google Scholar 

  • Hanania NA, Chapman KR, Sturtridge WC et al (1995) Doserelated decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 96:571–579

    Article  PubMed  CAS  Google Scholar 

  • Howarth PH, Bradding P, Montefort S et al. (1994) Mucosal inflammation and asthma. Am J Respir Crit Care Med 150:518–522

    Article  Google Scholar 

  • Jarvis B, Markham A (2000) Montelukast: a review of its therapeutic potential in persistent asthma. Drugs 59:891–928

    Article  PubMed  CAS  Google Scholar 

  • Knight DA, Stewart GA, Thompson PJ (1994) The respiratory epithelium and airway smooth muscle homeostasis: its relevance to asthma. Clin Exp Allergy 24:698–706

    Article  PubMed  CAS  Google Scholar 

  • Kroegel C, Herzog V, Knöchel B, et al (1996) 5-Lipoxigenase-Inhibitoren und Leukotrien-Rezeptorantagonisten. Arzneimittelther. 14:299–309

    Google Scholar 

  • Linden J (1994) Cloned adenosine A3-receptors. Pharmacological properties, species differences and receptor function. Trends Pharmacol Sci 15:298–306

    Article  PubMed  CAS  Google Scholar 

  • Lipworth BJ (1999) Modern drug treatment of chronic asthma. Brit Med J 318:380–383

    Article  PubMed  CAS  Google Scholar 

  • Lipworth BJ (1999) Leukotriene-receptor antagonists. Lancet 353:57–62

    Article  PubMed  CAS  Google Scholar 

  • Magnussen H (1993) Der schwere und lebensbedrohliche Asthmaanfall. Internist 36:779–784

    Google Scholar 

  • McFadden ER, Hejal R (1995) Asthma. Lancet 345:1215–1220

    Article  PubMed  Google Scholar 

  • McGill KA, Busse WW (1996) Zileuton. Lancet 348:519–524

    Article  PubMed  CAS  Google Scholar 

  • Milgrom H, Fick RB Jr, Su JQ et al. (1999) Treatment of allergic asthma with monoclonal anti-IgE antibody, rhuMAB-E25 Study Group. N Engl J Med 341:1966–1973

    Article  PubMed  CAS  Google Scholar 

  • Morley j (1994) K+ channel openers and suppresion of airway hyperreactivity. Trends Pharmacol Sci 15:463–468

    Article  PubMed  CAS  Google Scholar 

  • Pauwels RA (1989) New aspects of the therapeutic potential of theophyllin in asthma. J Allergy Clin Immunol 83:548–553

    Article  PubMed  CAS  Google Scholar 

  • Pauwels RA, Lofdahl CG, Postma DS et al. (1997) Effect of inhaled formoterol and budenoside on exacerbations of asthma. Formoterol and Corticosteroid Establishing Therapy (FACET) International Study Group. N Engl J Med 337:1405–1411

    Article  PubMed  CAS  Google Scholar 

  • Persson CGA (1987) The pharmacology of antiasthmatic xanthines and the role of adenosine. Asthma Rev 1:61–93

    Google Scholar 

  • Poole PJ, Black PN (2001) Mucolytic agents for chronic bronchitis (Cochrane Review). In: The Cochrane Library, Issue 1, 2001, Oxford.

    Google Scholar 

  • Rhoden KJ (1988) Inhibition of cholinergic neurotransmission in human airways by ß-2-adrenoceptors. J Appl Physiol 65:700–705

    PubMed  CAS  Google Scholar 

  • Richardson P (1987) Oral N-acetylcysteine: how does it act? Eur J Respir Dis 70:71–72

    PubMed  CAS  Google Scholar 

  • Schmidt M, Martin E (1994) Asthma und Antiasthmatika. Wissenschaftliche Verlagsgesellschaft, Stuttgart

    Google Scholar 

  • Sorkness CA (2001) Leukotriene receptor antagonists in the treatment of asthma. Pharmacotherapy 21:34S–37S

    Article  PubMed  CAS  Google Scholar 

  • Spitzer WO, Suissa S, Ernst P et al. (1992) The use of ß-ago-nists and the risk of death and near death from asthma. N Engl J Med 326:501–506

    Article  PubMed  CAS  Google Scholar 

  • Thesen R (1993) Colfosceril zur Surfactantsubstitution. Pharmazeut Ztg 138:1793–1798

    Google Scholar 

  • Torphy TJ (1994) ß-adrenoceptors, cAMP and airway smooth muscle relaxation: challenges to the dogma. Trends Pharmacol Sci 15:370–374

    Article  PubMed  CAS  Google Scholar 

  • Weinberger M, Hendeles L (1996) Theophylline in Asthma. NEJM 334:1380–1388

    Article  PubMed  CAS  Google Scholar 

  • Wettengel R, Berdel D, Hofmann D et al (1998) Asthmatherapie bei Kindern und Erwachsenen. Empfehlungen der Deutschen Atemwegsliga in der Deutschen Gesellschaft für Pneumologie. Med Klinik 93:639–650

    Article  CAS  Google Scholar 

  • Wettengel R (1999) Zum Kataraktrisiko durch inhalative Kortikoide. Pneumologie 53:409–410

    Article  PubMed  CAS  Google Scholar 

  • Wood-Baker R, Walters EH, Gibson P (2001) Corticosteroids for acute exacerbations of chronic obstructive pulmonary disease (Cochrane Review). In: The Cochrane Library, Issue 1, 2001, Oxford.

    Google Scholar 

  • Woolcock AJ (1990) ß-Agonists and asthma mortality. Drugs 40:653–656

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Eberhard Hackenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Fachbereich Humanmedizin — Institut für Pharmakologie, Freie Universität Berlin, Thielallee 67-73, 14195, Berlin, Germany

    Eckard Oberdisse

  2. Pharmakologisches Institut, Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg, Germany

    Eberhard Hackenthal

  3. Institut für Pharmakologie und Toxikologie, Universität Marburg/Lahn, Ketzerbach 63, 35032, Marburg, Germany

    Klaus Kuschinsky

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hackenthal, E. (2002). Pharmaka mit Wirkung auf den Respirationstrakt. In: Oberdisse, E., Hackenthal, E., Kuschinsky, K. (eds) Pharmakologie und Toxikologie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56314-0_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56314-0_31

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62634-0

  • Online ISBN: 978-3-642-56314-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation